In 2013, Johnson & Johnson spent more than $40 million advertising its drug products in professional health journals, meaning it comprises 7% of the total market share among all companies. Pfizer ranked second on the list with Forest rounding out the top three.
The percentage changes compare 2013 to 2012. For more information on these ad insights or other data, let one of us know.
Kantar Media sets the standard for accurate, comprehensive competitive advertising intelligence in the professional healthcare arena. Check back next month for updated data on the top products, classes, companies and category movers year-to-date.